Epsilon Healthcare Limited announced that Mr. Steven Xu has resigned as a director effective, 1 November 2022. Following Mr. Xu's resignation, Mr. Josh Cui has been appointed Non-Exec Chairman, and Mr. Alan Beasley, Non-Exec Deputy Chairman. Mr. Xu has been a director of the Company since 2018 in which time the Company has progressed into being the operator of a large scale TGA GMP toll manufacturer of medicinal cannabis and operator of one of Australia's medicinal cannabis clinic networks.

Mr. Xu's contributed with his significant expertise in finance, accounting, and corporate management and has been instrumental in bringing Epsilon to this stage. The Company thanks Mr. Xu greatly for his significant services over his tenure and wishes him well in his future endeavours. Following the recent changes, the Epsilon Board now consists of: Josh Cui (Non-Exec Chairman), Alan Beasley (Non-Exec Deputy Chairman), Stuart Cameron (Non-Exec) and Simon Rowe (Non-Exec).